Response to therapy of papillary thyroid cancer of known BRAF status.
Aldona KowalskaAgnieszka WalczykArtur KowalikIwona PałygaDanuta Gąsior-PerczakTomasz TrybekJanusz KopczyńskiMaciej KajorEstera MikinaMonika SzymonekKlaudia Gadawska-JuszczykDorota Szyska-SkrobotKatarzyna Lizis-KolusStefan HurejMagdalena ChrapekMałgorzata ChłopekStanisław GóźdźPublished in: Clinical endocrinology (2017)
Our data are consistent with those of other studies reporting a positive relation between BRAF V600E mutation and poor prognostic factors in PTC; however, the BRAF status did not significantly correlate with a response to therapy.